StockData

Calumet vs Quaker Chemical

CLMT and KWR side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CLMT and KWR compare

Calumet is the larger company, worth 1.7 times as much as Quaker Chemical ($4.4B against $2.6B).

Calumet grew revenue faster over the last twelve months (12.8% versus 8.7% for Quaker Chemical).

Quaker Chemical keeps more of each dollar of sales as profit, with a net margin of 4.8% compared with −3.0% at Calumet.

Quaker Chemical pays a dividend yielding 1.4%; Calumet does not pay one.

Quaker Chemical scores higher on the StockData Score (11 against 3 for Calumet), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCLMTKWR
Size and price
Market cap$4.4B$2.6B
Share price$49.65$150.95
Change, 1 year154%15.7%
Change, 5 years333%−44.2%
Beta (5Y)0.831.44
Employees1,5404,700
StockData Score
Total score311 (better)
Valuation score04 (better)
Growth score2 (better)0
Performance score11
Health score02 (better)
Dividend score04 (better)
Valuation
P/E–26.9×
P/S1.0× (better)1.3×
P/B–1.8×
EV/EBITDA36.2×14.8× (better)
P/FCF74.7×65.9× (better)
FCF yield1.3%1.5% (better)
Fair value–$155.70
Margin of safety–3.1%
Growth
Revenue growth (TTM)12.8% (better)8.7%
Revenue growth, 5Y average12.8% (better)5.9%
Profitability
Gross margin6.6%35.8% (better)
Operating margin1.0%7.6% (better)
Net margin−3.0%4.8% (better)
FCF margin1.3%1.9% (better)
Return on equity–7.0%
Return on invested capital3.5%5.2% (better)
Financial health
Debt / equity–0.63
Net debt / EBITDA11.953.23 (better)
Interest coverage0.2×3.8× (better)
Current ratio0.842.47 (better)
Altman Z-score1.332.48 (better)
Piotroski F-score55
Dividends and buybacks
Dividend yield–1.4%
Payout ratio–36.2%
Years of dividend growth–16
Dividend growth, 5Y average–5.0%
Shareholder yield0.00%1.4% (better)
Ownership
Held by institutions52.4%91.9%
Held by insiders20.5%22.4%
Insider net buying, 12 months−$20.7M−$208K (better)
Short interest, % of float5.1%13.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.